Home › Funds › Alpine Global Management, LLC › IMVT

Alpine Global Management, LLC position in IMVT

IMMUNOVANT INC COM · Health Care

Alpine Global Management, LLC reported holding 1,375,000 shares of IMVT (IMMUNOVANT INC COM) in its Q2 2026 13F filing — a position valued at US$53.0M, representing 8.89% of its reported portfolio and ranking #1 among its reported holdings. Alpine Global Management, LLC has disclosed IMVT holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.38M sh
Reported value held$52.98M
Portfolio Weight8.89%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Alpine Global Management, LLC's IMVT position evolved

Alpine Global Management, LLC first disclosed a stake in IMVT in Q3 2023 at 1,252,474 shares (US$48.1M). The position peaked in Q4 2025 at 2,626,692 shares, worth US$66.8M. Across 11 filings, Alpine Global Management, LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,375,000 shares valued at US$53.0M — a reduction of -1,251,692 shares quarter over quarter.. Notable position changes include a 35% increase in Q1 2024 (shares fell 18% over the following quarter), a 48% trim in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.25M $48.08M New
Q4 2023 1.40M $58.91M Add
Q1 2024 1.88M $60.83M Add
Q2 2024 1.91M $50.36M Add
Q3 2024 1.88M $53.68M Reduce
Q4 2024 2.16M $53.48M Add
Q1 2025 2.63M $44.89M Add
Q2 2025 2.63M $42.03M Hold
Q3 2025 2.75M $44.41M Add
Q4 2025 2.63M $66.77M Reduce
Q2 2026 1.38M $52.98M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC COM) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has Alpine Global Management, LLC held IMVT?

Alpine Global Management, LLC has disclosed IMVT holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

What is Alpine Global Management, LLC's current position in IMVT?

As of Q2 2026, Alpine Global Management, LLC holds 1.38M shares of IMVT (IMMUNOVANT INC COM), valued at $52.98M, representing 8.89% of its reported portfolio and ranking #1.

Has Alpine Global Management, LLC been buying or selling IMVT?

In the latest 13F filing (Q2 2026), Alpine Global Management, LLC reduced its position in IMVT. The position peaked in Q4 2025 at 2.63M shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.